Process And Product Qualification Of The Intercept Blood Systemfor Red Blood Cells With As-1 At Hoxworth Blood Center (Hbc)
Posted Date: Apr 18, 2024
- Investigator: Jose Cancelas
- Specialties:
- Type of Study: Drug
Pre-clinical qualification of a pathogen reduction method for red cell components using the amustalin S-303.
Criteria:
Healthy Volunteer Donors Who Have Consented To Donate Blood Components For Laboratory Research Will Undergo Either A Whole Blood Donation
Keywords:
Red Blood Cell Products, Transfusion, Pathogen Reduction
For More Information:
Jose A Cancelas
15133760250
jose.cancelas@uc.edu